unknown
Stage
2007
Founded
1
Investors
About
Mallinckrodt plc is a specialty pharmaceutical company that, following a merger with Endo, restructured to spin off its generics and sterile injectables business as Par Health and rebrand its specialty therapeutics business as Keenova. Par Health develops generics, sterile injectables and active pharmaceutical ingredients with a U.S.-focused manufacturing network, while Keenova focuses on specialty therapeutics across areas including immunology, urology, hepatology, ophthalmology, orthopedics, a
Explore Mallinckrodt plc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.